Atriva Fast Tracks Antiviral Candidate As Coronavirus Arrives In Germany
Working With Doctors To Test Against Virus
The antiviral specialist says MEK inhibitor could work against 2019-nCoV, but tests will take time.
You may also be interested in...
Codagenix, a company backed by Novartis, Merck and the Bill & Melinda Gates Foundation, has tied up with India’s Serum Institute to develop a vaccine against SARS-CoV-2, joining a heated race against the dreaded COVID-19 outbreak.
Beam is the latest allogeneic CAR-T developer to face a regulatory hold-up, but other candidates using its pioneering base-editing technology are now progressing.
AstraZeneca’s momentum is growing towards ‘industry-leading' revenue growth, but investors are focused on the operating margin, and concerned about when CEO Pascal Soriot will depart.